PLAINSBORO, N.J., June 11, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NasdaqGS:IART - News) announced today the closing of the private sale $165 million aggregate principal amount of senior convertible notes due 2010 (the ``2010 notes’’) and $165 million aggregate principal amount of senior convertible notes due 2012 (the ``2012 notes’’ and, together with the 2010 notes, the ``notes’’). The principal amount of each series of notes included $15 million in aggregate principal amount related to the initial purchasers options to purchase additional notes, which were exercised in full.
